Scarica l'app Stockscreener
19.52
1.46%
0.28
Dopo l'orario di chiusura:
19.52
Precedente Chiudi:
$19.24
Aprire:
$19.19
Volume 24 ore:
182.67K
Relative Volume:
0.53
Capitalizzazione di mercato:
$791.91M
Reddito:
-
Utile/perdita netta:
$-136.98M
Rapporto P/E:
-4.8557
EPS:
-4.02
Flusso di cassa netto:
$-126.63M
1 W Prestazione:
+1.61%
1M Prestazione:
+3.94%
6M Prestazione:
-11.09%
1 anno Prestazione:
-25.27%
Intervallo 1D:
$18.39
$19.64
Intervallo di 1 settimana:
$18.39
$20.63
Portata 52W:
$15.47
$36.37
Arrivent Biopharma Inc Stock (AVBP) Company Profile
Nome
Arrivent Biopharma Inc
Settore
Industria
Telefono
240-780-6356
Indirizzo
18 CAMPUS BLVD., NEWTOWN SQUARE
Confronta AVBP con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
AVBP
Arrivent Biopharma Inc
|
19.52 | 804.89M | 0 | -136.98M | -126.63M | -4.02 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Arrivent Biopharma Inc Stock (AVBP) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-07-10 | Ripresa | Goldman | Buy |
| 2025-03-20 | Iniziato | B. Riley Securities | Buy |
| 2025-03-10 | Iniziato | Guggenheim | Buy |
| 2024-07-22 | Iniziato | Oppenheimer | Outperform |
| 2024-04-30 | Iniziato | H.C. Wainwright | Buy |
| 2024-02-20 | Iniziato | Citigroup | Buy |
| 2024-02-20 | Iniziato | Goldman | Buy |
| 2024-02-20 | Iniziato | Jefferies | Buy |
Mostra tutto
Arrivent Biopharma Inc Borsa (AVBP) Ultime notizie
Does ArriVent BioPharma Inc. have pricing power2025 Buyback Activity & Precise Trade Entry Recommendations - khodrobank.com
Can ArriVent BioPharma Inc. hit a new high this month2025 Volume Leaders & High Conviction Investment Ideas - Newser
Will ArriVent BioPharma Inc. benefit from macro trendsJuly 2025 Closing Moves & AI Powered Buy/Sell Recommendations - Newser
Historical volatility pattern of ArriVent BioPharma Inc. visualizedMarket Movement Recap & Safe Entry Momentum Tips - Newser
Institutional Tools Highlight Unusual Flow in ArriVent BioPharma Inc.July 2025 Movers & Weekly Breakout Stock Alerts - beatles.ru
Institutional scanner results for ArriVent BioPharma Inc.Market Trend Review & Real-Time Volume Analysis Alerts - Newser
Earnings visualization tools for ArriVent BioPharma Inc.Fed Meeting & Technical Confirmation Alerts - Newser
Is this a good reentry point in ArriVent BioPharma Inc.Quarterly Portfolio Review & High Conviction Buy Zone Alerts - Newser
Nuveen LLC Takes $819,000 Position in ArriVent BioPharma, Inc. $AVBP - Defense World
Regression analysis insights on ArriVent BioPharma Inc. performanceMarket Rally & High Conviction Buy Zone Alerts - Newser
Real time breakdown of ArriVent BioPharma Inc. stock performance2025 Risk Factors & Low Risk High Reward Ideas - Newser
How high can ArriVent BioPharma Inc. stock goDip Buying & Free Fast Entry Momentum Trade Alerts - Newser
Will ArriVent BioPharma Inc. outperform the marketJuly 2025 PreEarnings & Precise Swing Trade Entry Alerts - Newser
Will breakout in ArriVent BioPharma Inc. lead to full recoveryEntry Point & Stock Market Timing Techniques - Newser
What to expect from ArriVent BioPharma Inc. in the next 30 daysJuly 2025 Fed Impact & Precise Buy Zone Tips - Newser
Is now a turning point for SmartKem Inc.July 2025 Market Mood & Breakout Confirmation Alerts - Newser
Published on: 2025-09-02 03:06:28 - Newser
Watch for Bullish Crossover in ArriVent BioPharma Inc. getLinesFromResByArray error: size == 0 - kangso.co.kr
Analyzing recovery setups for ArriVent BioPharma Inc. investors2025 Dividend Review & Community Consensus Trade Signals - Newser
What recovery options are there for ArriVent BioPharma Inc.July 2025 Trade Ideas & Weekly High Conviction Trade Ideas - Newser
Full technical analysis of ArriVent BioPharma Inc. stock2025 Breakouts & Breakdowns & Verified Entry Point Detection - Newser
Automated trading signals detected on ArriVent BioPharma Inc.Portfolio Performance Report & Consistent Profit Focused Trading Strategies - Newser
Risk adjusted return profile for ArriVent BioPharma Inc. analyzedPortfolio Update Summary & Proven Capital Preservation Methods - Newser
Volatility clustering patterns for ArriVent BioPharma Inc.2025 Short Interest & Safe Swing Trade Setup Alerts - Newser
Will ArriVent BioPharma Inc. stock go up soonMarket Growth Review & Low Risk High Reward Ideas - Newser
Understanding ArriVent BioPharma Inc.’s price movement2025 Trading Recap & Free Long-Term Investment Growth Plans - Newser
ArriVent BioPharma Inc. stock prediction for this weekStop Loss & Free Weekly Watchlist of Top Performers - Newser
What machine learning models say about ArriVent BioPharma Inc.July 2025 Movers & Breakout Confirmation Trade Signals - Newser
What are ArriVent BioPharma Inc.’s growth leversPortfolio Risk Summary & Verified Trade Idea Suggestions - sundaytimes.kr
Arrivent Biopharma Inc Azioni (AVBP) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Arrivent Biopharma Inc Azioni (AVBP) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| LaChapelle Robin | Chief Operating Officer |
Sep 19 '24 |
Option Exercise |
3.28 |
27,566 |
90,481 |
124,583 |
1.75%
1.11%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):